Why did Nvidia resume AI chip sales to China?
How are Trump's tariffs impacting US inflation?
What caused JPMorgan’s profit to fall despite beat?
Why are crypto bills stalling in the House?
How will Apple’s rare-earth deal affect supply chains?
What’s behind Tesla’s North American sales leadership exit?
How did BlackRock’s big client redemption affect shares?
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
finance.yahoo.com/news/sino-biopharma-spends-951m-acquire-154429325.html
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia-Pacific pharmaceutical arena this year.
Sino already owns a 4.91% stake courtesy of an…
This story appeared on finance.yahoo.com, 2025-07-15 15:44:29.